Studies indicate a correlation between elevated HLA‐E expression levels and unfavorable clinical outcomes in different cancer types, such as glioblastoma, ovarian carcinoma, multiple myeloma, vulvar squamous cell carcinoma, and gastric cancer [29, 30, 31, 32, 33]. This evidence concerns the gene HLA-E and plasma cell myeloma.